Pittenger & Anderson Inc’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.53K | Hold |
11
| – | – | ﹤0.01% | 478 |
|
|
2025
Q4 | $1.35K | Hold |
11
| – | – | ﹤0.01% | 484 |
|
|
2025
Q3 | $1.22K | Buy |
+11
| New | +$1.25K | ﹤0.01% | 433 |
|
|
2025
Q2 | – | Sell |
-579
| Closed | -$64.9K | – | 433 |
|
|
2025
Q1 | $64.9K | Buy |
+579
| New | +$59.7K | ﹤0.01% | 277 |
|
|
2024
Q1 | – | Sell |
-450
| Closed | -$36.5K | – | 439 |
|
|
2023
Q4 | $36.5K | Hold |
450
| – | – | ﹤0.01% | 306 |
|
|
2023
Q3 | $33.7K | Hold |
450
| – | – | ﹤0.01% | 290 |
|
|
2023
Q2 | $34.7K | Buy |
+450
| New | +$35.9K | ﹤0.01% | 292 |
|
|
2022
Q2 | – | Sell |
-26
| Closed | -$2K | – | 445 |
|
|
2022
Q1 | $2K | Buy |
+26
| New | +$1.66K | ﹤0.01% | 428 |
|
|
2019
Q1 | – | Sell |
-1,130
| Closed | -$71K | – | 380 |
|
|
2018
Q4 | $71K | Hold |
1,130
| – | – | 0.01% | 242 |
|
|
2018
Q3 | $87K | Buy |
1,130
+800
| +242% | +$60.4K | 0.01% | 243 |
|
|
2018
Q2 | $23K | Sell |
330
-170
| -34% | -$12K | ﹤0.01% | 299 |
|
|
2018
Q1 | $38K | Buy |
500
+70
| +16% | +$5.57K | ﹤0.01% | 279 |
|
|
2017
Q4 | $31K | Buy |
430
+200
| +87% | +$15.2K | ﹤0.01% | 295 |
|
|
2017
Q3 | $19K | Buy |
230
+105
| +84% | +$8.03K | ﹤0.01% | 308 |
|
|
2017
Q2 | $9K | Buy |
125
+35
| +39% | +$2.33K | ﹤0.01% | 334 |
|
|
2017
Q1 | $6K | Sell |
90
-4,275
| -98% | -$301K | ﹤0.01% | 321 |
|
|
2016
Q4 | $313K | Sell |
4,365
-925
| -17% | -$68.8K | 0.03% | 206 |
|
|
2016
Q3 | $419K | Sell |
5,290
-8,913
| -63% | -$724K | 0.05% | 193 |
|
|
2016
Q2 | $1.19M | Sell |
14,203
-48,195
| -77% | -$4.28M | 0.13% | 156 |
|
|
2016
Q1 | $5.73M | Buy |
62,398
+17,145
| +38% | +$1.55M | 0.67% | 28 |
|
|
2015
Q4 | $4.58M | Buy |
45,253
+1,823
| +4% | +$190K | 0.57% | 41 |
|
|
2015
Q3 | $4.26M | Buy |
43,430
+4,960
| +13% | +$551K | 0.56% | 37 |
|
|
2015
Q2 | $4.5M | Buy |
38,470
+7,785
| +25% | +$851K | 0.58% | 33 |
|
|
2015
Q1 | $3.01M | Buy |
30,685
+12,645
| +70% | +$1.28M | 0.39% | 67 |
|
|
2014
Q4 | $1.7M | Buy |
18,040
+16,870
| +1,442% | +$1.74M | 0.22% | 114 |
|
|
2014
Q3 | $125K | Buy |
1,170
+110
| +10% | +$10.8K | 0.02% | 241 |
|
|
2014
Q2 | $88K | Buy |
+1,060
| New | +$82.5K | 0.01% | 264 |
|
|
2013
Q3 | – | Sell |
-10,350
| Closed | -$531K | – | 281 |
|
|
2013
Q2 | $531K | Buy |
+10,350
| New | +$539K | 0.09% | 192 |
|
Other funds holding GILD
VCM
VPM
Pittenger & Anderson Inc's GILD Position: Q1 2026 in Review
Pittenger & Anderson Inc held its Gilead Sciences (GILD) position steady in Q1 2026 at 11 shares worth $1.53K. The position accounts for ﹤0.01% of the portfolio, ranked #478.
Pittenger & Anderson Inc first reported a position in GILD in Q2 2013 and has held it in 28 quarters since. The position peaked at $5.73M in Q1 2016. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Pittenger & Anderson Inc held 11 shares of Gilead Sciences worth $1.53K as of Q1 2026.
- Pittenger & Anderson Inc left its Gilead Sciences share count unchanged in Q1 2026.
- Gilead Sciences made up ﹤0.01% of Pittenger & Anderson Inc's portfolio in Q1 2026, its #478 holding.
- Pittenger & Anderson Inc first reported a position in Gilead Sciences in Q2 2013 and has held it in 28 quarters since.
- Pittenger & Anderson Inc's Gilead Sciences position peaked at $5.73M in Q1 2016.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Pittenger & Anderson Inc's 13F filing for Q1 2026, filed 1 May 2026.